TITLE

TREATMENT OF CHRONIC THROMBOEMBOLISM WITH ARVIN, ORAL FIBRINOLYTICS AND STANDARD ANTICOAGULANTS

AUTHOR(S)
Kounis, Nicholas G.; Evans, W. Howel
PUB. DATE
March 1977
SOURCE
Vascular Surgery;Mar/Apr1977, Vol. 11 Issue 2, p68
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In five patients suffering from recurrent deep venous thrombosis and pulmonary embolism, a therapeutic combination was applied including Arvin, Fearnley's regime and standard anticoagulants. In two patients complete remission of the disease seemed to he achieved during the following two years. The rest of the patients received repeated courses of the regime and are still being investigated.
ACCESSION #
16941745

 

Related Articles

  • Advances in Antithrombotic Agents. Chakrabarti, Ranjan; Das, Saibal Kumar // Cardiovascular & Hematological Agents in Medicinal Chemistry;2007, Vol. 5 Issue 3, p175 

    Thrombosis is the condition where an imbalance in the homeostatic mechanism results in unwanted intravascular thrombus formation. Imbalances in this highly regulated process of coagulation and anticoagulation can lead to a variety of pathophysiological conditions leading to stroke, pulmonary...

  • MODELING, ADME SCREENING & QSAR STUDIES ON FACTOR-XA INHIBITORS. NARAYANAN, SIBI; VELMURUGAN, D. // International Journal of Pharma & Bio Sciences;Apr2014, Vol. 5 Issue 2, pP-19 

    Thromboembolic disease is caused by improper functioning of the blood coagulation process. The serine protease Factor Xa plays a central role in the coagulation cascade. FXa inhibitors have been identified to maintain a patient's blood level within the therapeutic range and also shown to...

  • Evidence-Based Medicine Requires Appropriate Clinical Context. McNutt, Robert A.; Livingston, Edward H. // JAMA: Journal of the American Medical Association;2/3/2010, Vol. 303 Issue 5, p454 

    The authors comment on a study which examined the occurrence of venous thromboembolism (VTE) in patients with a single negative whole-leg compression ultrasound (CUS) result who did not receive anticoagulation. The meta-analysis of 7 studies, published within the issue, suggests that withholding...

  • Characterization of the coagulation system in healthy dolphins: the coagulation factors, natural anticoagulants, and fibrinolytic products. Tibbs, Rita F.; Elghetany, M. Tarek; Tran, Lethu T.; van Bonn, W.; Romano, T.; Cowan, Daniel F. // Comparative Clinical Pathology;Nov2005, Vol. 14 Issue 2, p95 

    In dolphins, blood pooling and acidosis from lack of oxygenation with prolonged underwater stay are not associated with intravascular clotting as it would be in terrestrial mammals, while shed blood clots promptly, and intravascular clots form after death. This intriguing physiologic adaptation...

  • Commentary. Crowther, Mark // Evidence Based Medicine;Apr2007, Vol. 12 Issue 2, p45 

    The article expresses the author's view on the publication of the study on the risk factors that predict recurrent venous thromboembolism (VTE). The author mentions that the issue on the optimal duration of oral coagulation therapy is still being debated because of its risk, the benefit ratio of...

  • A MOUSE MINUS CLOTTING FACTOR GENE. Kingman, Sharon // BioWorld Today;2/11/2014, Vol. 25 Issue 28, p9 

    The article focuses on the anticoagulation therapy experiments using the antibody 3F7 developed in 2005 by Swedish, Australian and German researchers. The study showed that mice which were manipulated genetically to block the clotting factor XII were protected from the development of thrombosis....

  • tirofiban.  // Royal Society of Medicine: Medicines;2002, p536 

    This article provides information on tirofiban which can be used to prevent thrombosis or blood-clot formation. The antithrombic drug works by stopping platelets sticking to one another or to the walls of blood vessels. It can be used together with heparin and aspirin to prevent thrombosis in...

  • Antithrombotic therapy and survival in patients with malignant disease. Kakkar, A. K.; Macbeth, F. // British Journal of Cancer;4/2/2010 Supplement 1, Vol. 102, pS24 

    A broad range of studies suggest a two-way relationship between cancer and venous thromboembolism (VTE). Patients with cancer have consistently been shown to be at elevated risk for VTE; this risk is partly driven by an intrinsic hypercoagulable state elicited by the tumour itself. Conversely,...

  • INTRAVENOUS ADMINISTRATION OF FIBRINOLYSIN: ITS SYSTEMIC TOXICITY AND EFFECT UPON COMPONENTS OF THE COAGULATION MECHANISM. Moser, Kenneth M. // Angiology;Aug1959 Part 2, Vol. 10 Issue 4, p253 

    1. In the doses used, the toxic potential of fibrinolysin is limited primarily to temperature elevation. In the absence of prophylactic medication, a febrile reaction occurred in 44.4 per cent of the patients, and could be correlated only with the presence of extensive thrombotic material. 2....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics